Jennifer Villasenor-park - Faculty Biosketch

Jennifer Villasenor-Park, MD/PhD

Associate Professor of Clinical Dermatology

Department: Dermatology

Contact information

1000 Floral Vale Boulevard
Suite 100
Yardley, PA 19067

Education:
B.A. (Molecular and Cellular Biology; Psychology)
University of California at Berkeley, 1999.
Ph.D.
Harvard Medical School, 2007.
M.D.
Harvard Medical School, 2009.

Post-Graduate Training
Preliminary Medicine Internship , University of Massachusetts , 2009-2010.
Dermatology Resident and 2+2 Investigative Research Fellowship, University of Pittsburgh Medical Center, 2010-2014.

Certifications
American Board of Dermatology, 2013.

Permanent link

> Perelman School of Medicine > Faculty > Details

Selected Publications

Elghawy O, Yang AG, Sussman JH, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Villasenor-Park J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK: Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome. J Am Acad Dermatol 92(3): 634-36, Mar 2025.

Villasenor-Park J, Chung J, Kim EJ: Cutaneous B-Cell Lymphomas. Hematol Oncol Clin North Am 38(5): 1111-31, Oct 2024.

Himeles JR, Holton J, Vittorio C, Rook AH, Haun P, Villasenor-Park J, Samimi S, Kim EJ: Recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T-cell Lymphoma. J Am Acad Dermatol 88(3): 680-83, Mar 2023.

Villasenor-Park J, Kim E: Chapter 113: Sezary Syndrome in "Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment. McGraw-Hill LLC. McGraw-Hill LLC, Page: 502, 2023.

Weiner DM, Clark AK, Bhansali RS, Pappas-Taffer L, Barta SK, Villasenor-Park J, Haun PL, Vittorio CC, Rook AH, Kim EJ, Samimi SS: Usage and safety of topical tacrolimus in patients with mycosis fungoides. Clin Exp Dermatol 47(6): 1200-01, Jun 2022.

Xu Z, Margolskee E, Villasenor-Park J, Rubin AI, Khurana MC: A healthy 16-year-old boy presenting with multifocal asymptomatic subcutaneous nodules. Pediatr Dermatol 39(1): E8-E10, Jan 2022.

Lewis DJ, Haun PL, Samimi SS, Vittorio CC, Villasenor-Park J, Barta SK, Landsburg DJ, Svoboda J, Nasta SD, Schuster SJ, Rook AH, Kim EJ: Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome. JAMA Dermatol 157(3): 317-21, Mar 2021.

Durgin JS, Jariwala NN, Wysocka M, Zhang KK, Maity A, Benoit B, Plastaras JP, Lewis DJ, Rosenthal JM, Teague JE, Berg S, Del Guzzo C, Kim EJ, Vittorio C, Huan PL, Samimi SS, Villasenor-Park J, Inverso J, Clark RA, Rook AH: Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis. JAMA Dermatol 157(1): 90-95, Jan 2021.

Villasenor-Park J: Dermatologic Surgery in Pregnancy in "Cutaneous Disorders of Pregnancy" Springer Nature Link. Kelly H. Tyler (eds.). Springer Nature Link, Page: 113-121, Jul 2020.

Villasenor-Park J: Skin Cancer in Pregnancy in "Cutaneous Disorders of Pregnancy" Springer Nature Link. Kelly H. Tyler (eds.). Springer Nature Link, Page: 89-111, Jul 2020.